ArticleHeliyon2024
A wearable telehealth system for the monitoring of parameters related to heart failure.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 9 citations in OpenAlex.
- A wearable belt for non-invasive monitoring of heart failure parameters.Sensing and Bio-Sensing Research · 2025Article
- Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation.Medicina (Kaunas, Lithuania) · 2025Review
- Advances in Cardiovascular Wearable Devices.Biosensors · 2024Review
- A scoping review on advancements in noninvasive wearable technology for heart failure management.NPJ digital medicine · 2024Article
- Trustworthy AI in Telehealth: Navigating Challenges, Ethical Considerations, and Future Opportunities for Equitable Healthcare Delivery.Healthcare technology lettersReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is a cardiovascular disease in which heart fails to pump sufficient blood required by the body. Significant signs of worsening heart failure include decreased thoracic impedance, increased heart rate, irregular electrocardiogram (ECG), and lack of motion activity of the patient. Heart failure can be better managed if monitored continuously and in real-time. The existing solutions for continuous monitoring of these parameters are invasive and hence are not only expensive but can also cause serious health risks. This paper discusses the development of a telehealth system that consists of an Internet of Things including a wearable device connected to a cloud-based database and a mobile application using Wi-Fi. The wearable device is a noninvasive monitor that consists of different sensors embedded with a microcontroller and can be a potential solution for better management of heart failure. It continuously monitors the above-mentioned parameters and sends data to the mobile application using a cloud-based system. The mobile application has separate portals for patients and doctors where doctor can monitor a specific patient enrolled under his profile. The performance of the developed device is validated in 10 healthy individuals.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.